In contrast, MDA-MB-231 is a triple-negative breast cancer (TNBC), a specific subtype that lacks the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 [53,54]. Here, ERBB2 is linked to triple-negative breast carcinoma.